Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
January 8, 2019
Spiegel
The article examines how FDNA’s advanced AI technology is transforming the diagnosis of rare hereditary diseases. FDNA’s platform utilizes facial recognition algorithms to analyze patients’ facial features, identifying subtle phenotypic markers indicative of various genetic disorders. By comparing these markers against a comprehensive database, the AI can expedite the diagnosis of rare hereditary diseases with remarkable accuracy and speed, which traditional methods may miss. This breakthrough aids in early detection and personalized treatment plans, improving patient outcomes. The article emphasizes the revolutionary impact of FDNA’s AI technology in the medical field, particularly in diagnosing and managing rare genetic conditions.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…